Isolation of Terbinafine-Resistant Trichophyton rubrum from Onychomycosis Patients Who Failed Treatment at an Academic Center in New York, United States

• Published in: Journal of fungi (Basel) Vol. 9; no. 7; p. 710
• Main Authors: Hwang, Jonathan K, Bakotic, Wayne L, Gold, Jeremy A W, Magro, Cynthia M, Lipner, Shari R
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 28.06.2023; MDPI
• Subjects: Amino acids; antifungal resistance; antimicrobial resistance; antimicrobials; Brief Report; Clinical medicine; FDA approval; Histopathology; Hypertension; Mutation; nail diseases; nails; Onychomycosis; Patients; Prevention; Public health; Surveillance; Terbinafine; Trichophyton rubrum; New York; United States > US; nail diseases; antimicrobials; antimicrobial resistance; nails; antifungal resistance
• ISSN: 2309-608X; 2309-608X
• DOI: 10.3390/jof9070710

Onychomycosis is a common nail infection. Terbinafine-resistant dermatophyte infections pose an emerging global public health concern, but few cases have been described in the United States. We retrospectively reviewed and characterized clinical, histopathological, and mycological features of patients with mycologically confirmed onychomycosis who failed oral terbinafine treatment for onychomycosis at a U.S. academic nail referral center and ascertained for terbinafine-resistant isolates. During 1 June 2022-31 January 2023 at Weill Cornell Medicine in New York City, USA, 96 patients with mycologically confirmed onychomycosis were treated with oral terbinafine. Among 64 patients with adequate follow-up, 36 had clinical or complete cure. Of 28 patients who failed treatment, 17 underwent terbinafine resistance testing. with terbinafine resistance-conferring mutations was isolated from two patients. Overall, terbinafine failures for onychomycosis were relatively common, with some cases associated with terbinafine-resistant infections. These findings underscore the need for a clinical awareness of this emerging problem and public health efforts to monitor and prevent spread. We highlight the importance of diagnostic testing and species identification for onychomycosis patients and the increasingly important role of fungal identification and susceptibility testing to guide therapy.